Ten years ago, the World Health Organization added mycetoma to its official list of neglected tropical diseases. Caused by ...

Is the FDA taking inconsistent approaches to Duchenne drugs? And how will a new batch of drug executives shake up their ...

In win for RFK Jr., Senate committee sends nominations of Erica Schwartz for CDC director and Sean Kaufman for ASPR to full ...

Welcome to STAT’s live blog of a meeting, convened by the Food and Drug Administration, to review Replimune’s experimental treatment for melanoma. The FDA’s Cellular, Tissue ...

Patients, advocates, and experts fear the difficulty in documenting a frailty exemption to Medicaid work requirements will ...

An FDA advisory panel concluded clinical data for a Capricor treatment for Duchenne muscular dystrophy did not provide ...

Students working in fields eligible for NSF funding will be able to participate, including chemistry, engineering, and basic ...

Anil Oza is a general assignment reporter at STAT focused on the NIH and health equity. You can reach him on Signal at aniloza.16. BOSTON — In an order issued Thursday, a federal judge denied 26 ...

The authors were among the writers of a recent Council on Foreign Relations report on U.S. biopharma dependence on China. First Opinion is STAT’s platform for interesting, illuminating, and ...

Allison covers what hot startups are getting up to, and who’s financing them. She is also co-host of the weekly biotech podcast, “The Readout Loud.” You can reach Allison on Signal at AllisonDeAngelis ...

Latigo Biotherapeutics published positive data for an acute-pain drug meant to rival a Vertex medicine already on the market ...

The U.S. Federal Trade Commission sued telehealth company Hims & Hers alleging business practices that agency says misled ...